Tech Company Financing Transactions
NeurAxon Funding Round
BDC Venture Capital, Delphi Ventures and H.I.G. Capital participated in a $8.8 million capital raise for NeurAxon. The round was announced on 12/30/2009.
Transaction Overview
Company Name
Announced On
12/30/2009
Transaction Type
Debt
Amount
$8,750,000
Round
Undisclosed
Investors
Proceeds Purpose
NeurAxon will use the net proceeds from the financing to support ongoing research and development efforts for its internally generated pipeline of selective inhibitors of nNOS, an enzyme involved in modulating pain and central nervous system neuronal sensitization.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
16-1375 Southdown Rd. 318
Mississauga ON, L5J 2Z1
Canada
Mississauga ON, L5J 2Z1
Canada
Phone
Website
Email Address
Overview
NeurAxon is a leader in discovering and developing next generation pain therapeutics focused on the inhibition of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous system neuronal sensitization.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
John Andrews
VP - Regulatory Affairs
Tom Lategan
Browse more venture capital transactions:
Prev: 12/30/2009: Produced Water Absorbents venture capital transaction
Next: 12/31/2009: One Kings Lane venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs